ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106486 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106486; 2) Community: the network communities that were significantly associated with the response to NSC 106486; 3) Molecule: the relationships between components within communities and NSC 106486; 4) MDR: the compounds that were significantly associated with the NSC 106486.

NSC Compound Enrichment Correlation
NSC 622924 Null 0.00485717408280857 -0.22527315
NSC 625495 Antimony, dibromo(1-piperidinecarbodithioato-S,S')-, (T-4)- 0.00485717408280857 0.20005282
NSC 679092 Null 0.00485717408280857 -0.22338479
NSC 736443 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide 0.00485717408280857 0.2063406
NSC 743694 Null 0.00485717408280857 0.34586205
NSC 745449 Null 0.00485717408280857 0.20349551
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.00486817664672777 0.15936448
NSC 169774 Bromocriptine methanesulfonate 0.00486817664672777 0.14763268
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.00486817664672777 0.19931393
NSC 254677 Phomazarin 0.00486817664672777 -0.11255677
Total:119  Current:23    [First] [Prev] [Next] [Last]